ELVNENLIVEN THERAPEUTICS INC
CUSIP 29337E102 · common stock
3 tracked investors held ENLIVEN THERAPEUTICS INC (ELVN) at the end of Q3 2026, worth $83M in total. The largest holder was Julian Baker, with 0.2% of its portfolio. Perceptive Advisors opened a new position this quarter.
Holders · Q3 2026
3
New holders
1
Value held
$83M
Quarter-end price (est.)
$45.84
Investors holding ELVN · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Julian Baker Baker Bros. Advisors LP | 0.20% | 905,191 | $41.5M | HOLD |
| Perceptive Advisors Perceptive Advisors LLC | 0.37% | 462,506 | $21.2M | NEW |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.86% | 442,682 | $20.3M | ADD+14.2% |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Ron Baron | 0.00% | 7,500 | $380.6K | EXIT |